WALTHAM, Mass., Feb. 5, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Leerink Global Healthcare Conference at the Waldorf Astoria in New York City on February 12, 2015 at 11:10 AM Eastern time. A live webcast of this presentation will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days following the conference.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
CONTACT: For additional information, please contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations 1.781.325.1116 firstname.lastname@example.org